Literature DB >> 1316915

Ultrastructural immunogold localization of prostaglandin endoperoxide synthase (cyclooxygenase) to non-membrane-bound cytoplasmic lipid bodies in human lung mast cells, alveolar macrophages, type II pneumocytes, and neutrophils.

A M Dvorak1, E Morgan, R P Schleimer, S W Ryeom, L M Lichtenstein, P F Weller.   

Abstract

Lipid bodies are non-membrane-bound, lipid-rich cytoplasmic inclusions that occur in many mammalian cell types. Because lipid bodies are more prominent in cells associated with inflammation and are repositories of arachidonyl-phospholipids, a role for lipid bodies in the oxidative metabolism of arachidonic acid to form eicosanoids has been suggested. To evaluate further whether lipid bodies, in addition to serving as non-membranous sources of substrate arachidonate, are involved in eicosanoid formation, we used cells isolated from human lung to investigate the intracellular localization of prostaglandin endoperoxide (PGH) synthase (cyclooxygenase), the key initial, rate-limiting enzyme in the formation of prostaglandins and thromboxanes. Isolated lung cells containing a mixture of mast cells, alveolar macrophages, Type II alveolar pneumocytes, and neutrophils from short-term cultures were fixed in suspension in a dilute aldehyde mixture, post-fixed in osmium tetroxide, stained en bloc with uranyl acetate, dehydrated in a graded series of alcohols, and embedded in Epon. A post-embedding immunogold procedure was used with a primary PGH synthase monoclonal antibody and 20-nm gold-conjugated secondary antibody to demonstrate enzyme locations. Specificity controls were also done. We found PGH synthase in lipid bodies of human lung mast cells, alveolar macrophages, Type II alveolar pneumocytes, and neutrophils. Specific secretory and lysosomal granules and plasma membranes did not express PGH synthase. Specificity controls, including omission of the primary antibody or substitution with an irrelevant antibody, were negative. Absorption of the specific PGH synthase antibody with purified solid-phase PGH synthase resulted in a marked reduction of label in lipid bodies of all four cell types. These findings establish the presence of PGH synthase in lipid bodies of human lung mast cells, alveolar macrophages, Type II alveolar pneumocytes, and neutrophils and, in concert with previous studies, suggest that these cytoplasmic lipid-rich organelles may be non-membrane sites of eicosanoid formation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316915     DOI: 10.1177/40.6.1316915

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  30 in total

1.  Role of prostaglandin F2α production in lipid bodies from Leishmania infantum chagasi: insights on virulence.

Authors:  Théo Araújo-Santos; Nilda E Rodríguez; Sara Moura-Pontes; Upasna Gaur Dixt; Daniel R Abánades; Patrícia T Bozza; Mary E Wilson; Valéria Matos Borges
Journal:  J Infect Dis       Date:  2014-05-21       Impact factor: 5.226

Review 2.  Lipid droplets in leukocytes: Organelles linked to inflammatory responses.

Authors:  Rossana C N Melo; Peter F Weller
Journal:  Exp Cell Res       Date:  2015-10-29       Impact factor: 3.905

3.  LEUKOCYTE LIPID BODIES - STRUCTURE AND FUNCTION AS "EICOSASOMES".

Authors:  Peter F Weller
Journal:  Trans Am Clin Climatol Assoc       Date:  2016

4.  Insulin-containing lipogenic stimuli suppress mast cell degranulation potential and up-regulate lipid body biogenesis and eicosanoid secretion in a PPARγ-independent manner.

Authors:  William E Greineisen; Lori M N Shimoda; Kristina Maaetoft-Udsen; Helen Turner
Journal:  J Leukoc Biol       Date:  2012-06-15       Impact factor: 4.962

5.  Fatty acids from very low-density lipoprotein lipolysis products induce lipid droplet accumulation in human monocytes.

Authors:  Laura J den Hartigh; Jaime E Connolly-Rohrbach; Samantha Fore; Thomas R Huser; John C Rutledge
Journal:  J Immunol       Date:  2010-03-05       Impact factor: 5.422

Review 6.  Not just fat: the structure and function of the lipid droplet.

Authors:  Toyoshi Fujimoto; Robert G Parton
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

7.  Comparative analysis of lipotoxicity induced by endocrine, pharmacological, and innate immune stimuli in rat basophilic leukemia cells.

Authors:  Kristina Maaetoft-Udsen; William E Greineisen; Johnny Tudela Aldan; Hazelle Magaoay; Cheryll Ligohr; Lori M N Shimoda; Carl Sung; Helen Turner
Journal:  J Immunotoxicol       Date:  2014-12-24       Impact factor: 3.000

8.  Roles and origins of leukocyte lipid bodies: proteomic and ultrastructural studies.

Authors:  Hsiao-Ching Wan; Rossana C N Melo; Zhoung Jin; Ann M Dvorak; Peter F Weller
Journal:  FASEB J       Date:  2006-11-29       Impact factor: 5.191

9.  Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin.

Authors:  P T Bozza; J L Payne; S G Morham; R Langenbach; O Smithies; P F Weller
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

Review 10.  Unraveling the complexity of lipid body organelles in human eosinophils.

Authors:  Rossana C N Melo; Peter F Weller
Journal:  J Leukoc Biol       Date:  2014-09-10       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.